Skip to main content

news

Freshfields Bruckhaus Deringer, Gibson, Dunn & Crutcher, King & Wood Mallesons and DLA Piper have advised Chinese biopharma company Hutchmed on its HK$4.17 billion ($537 million) secondary listing in Hong Kong.

Linklaters, Davis Polk & Wardwell and JunHe are counselling the joint sponsors and underwriters, namely Morgan Stanley Asia, Jefferies Hong Kong and China International Capital Corporation.

Listed on the AIM market of the London Stock Exchange since 2006, Hutchmed also has American Depositary Shares (ADSs) listed on the Nasdaq Global Select Market. It is a biopharmaceutical company focused on the discovery, development and commercialisation of targeted therapies and immunotherapies for the treatment of patients with cancer and immunological diseases.

Partners Kevin Cheung and Christopher Yip led the Linklaters team. Conyers is providing offshore legal advice to the issuer.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com.

Related Articles

Deals

CAM, Trilegal, Khaitan, IndusLaw act on HUL’s $350 mln Minimalist deal

by Nimitt Dixit |

In the first big M&A deal in India this year, leading firm Cyril Amarchand Mangaldas has guided FMCG major Hindustan Unilever (HUL) on its acquisition of 90.5 percent stake in Jaipur-based skincare startup Minimalist for close to $350 million (29.5 billion rupees).

Deals

7 international, Indian firms act on Kedaara Capital’s $350 mln U.S. bet

by Nimitt Dixit |

Akin Gump Strauss Hauer & Feld, Quillon Partners, and Kelley Drye & Warren have advised Indian private equity firm Kedaara Capital on its maiden bet in the data analytics and AI solutions market, committing $350 million strategic investment to San Jose, California-based Impetus Technologies.

Deals

SAM, Latham guide Hexaware’s upcoming $1.2 bln India IPO

by Nimitt Dixit |

Indian law firm Shardul Amarchand Mangaldas & Co has been mandated to assist Hexaware Technologies, an AI-focused tech company backed by Carlyle Group, on its upcoming initial public offering (IPO) in India, which is expected to raise $1.2 billion.